SE7609719L - Forfarande for framstellning av kvaternera salter - Google Patents
Forfarande for framstellning av kvaternera salterInfo
- Publication number
- SE7609719L SE7609719L SE7609719A SE7609719A SE7609719L SE 7609719 L SE7609719 L SE 7609719L SE 7609719 A SE7609719 A SE 7609719A SE 7609719 A SE7609719 A SE 7609719A SE 7609719 L SE7609719 L SE 7609719L
- Authority
- SE
- Sweden
- Prior art keywords
- quaternera
- salts
- procedure
- preparation
- quaternera salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/48—Aldehydo radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60991475A | 1975-09-03 | 1975-09-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7609719L true SE7609719L (sv) | 1977-03-04 |
SE429044B SE429044B (sv) | 1983-08-08 |
Family
ID=24442870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7609719A SE429044B (sv) | 1975-09-03 | 1976-09-02 | Analogiforfarande for framstellning av imidazo-pyridiniumsalter |
Country Status (15)
Country | Link |
---|---|
US (1) | US4163745A (sv) |
JP (1) | JPS5233693A (sv) |
AT (1) | AT357158B (sv) |
BE (1) | BE845767A (sv) |
CA (1) | CA1063115A (sv) |
DE (1) | DE2634910C3 (sv) |
DK (1) | DK396676A (sv) |
ES (1) | ES451175A1 (sv) |
FR (1) | FR2322597A1 (sv) |
GB (1) | GB1519717A (sv) |
IE (1) | IE43313B1 (sv) |
LU (1) | LU75719A1 (sv) |
MX (1) | MX4817E (sv) |
NL (1) | NL7609772A (sv) |
SE (1) | SE429044B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1173196B (it) * | 1984-02-02 | 1987-06-18 | Bellon Roger Schoum Rbs Pharma | Composti imidazopiridinici farmacologicamente attivi |
EP0375819A1 (en) * | 1988-12-20 | 1990-07-04 | Merrell Dow Pharmaceuticals Inc. | Novel derivatives of 1,7'-[imidazo-[1,2-a]pyridine]5'-(6'H)ones |
KR20050008849A (ko) * | 2002-06-25 | 2005-01-21 | 교와 핫꼬 고교 가부시끼가이샤 | 2 환성 복소환 화합물 |
ES2522717B1 (es) * | 2013-05-14 | 2015-06-24 | Universidad De Alcalá | Nuevos compuestos inhibidores de la proteina tirosina fosfatasa 1B |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1964282U (de) | 1967-04-01 | 1967-07-20 | Purrmann & Herr G M B H | Wandler. |
US3557114A (en) | 1968-12-23 | 1971-01-19 | Merck & Co Inc | 1-substituted-3-(2-pyrimidinyl) imidazolium salts |
-
1976
- 1976-05-25 IE IE1102/76A patent/IE43313B1/en unknown
- 1976-08-03 DE DE2634910A patent/DE2634910C3/de not_active Expired
- 1976-08-09 GB GB33152/76A patent/GB1519717A/en not_active Expired
- 1976-08-19 CA CA259,427A patent/CA1063115A/en not_active Expired
- 1976-08-25 MX MX764851U patent/MX4817E/es unknown
- 1976-09-02 SE SE7609719A patent/SE429044B/sv unknown
- 1976-09-02 NL NL7609772A patent/NL7609772A/xx not_active Application Discontinuation
- 1976-09-02 BE BE1007600A patent/BE845767A/xx not_active IP Right Cessation
- 1976-09-02 DK DK396676A patent/DK396676A/da not_active Application Discontinuation
- 1976-09-02 ES ES451175A patent/ES451175A1/es not_active Expired
- 1976-09-03 AT AT653976A patent/AT357158B/de not_active IP Right Cessation
- 1976-09-03 JP JP51105709A patent/JPS5233693A/ja active Granted
- 1976-09-03 LU LU75719A patent/LU75719A1/xx unknown
- 1976-09-03 FR FR7626681A patent/FR2322597A1/fr active Granted
-
1977
- 1977-08-08 US US05/822,414 patent/US4163745A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS5437158B2 (sv) | 1979-11-13 |
SE429044B (sv) | 1983-08-08 |
LU75719A1 (sv) | 1977-06-15 |
GB1519717A (en) | 1978-08-02 |
BE845767A (fr) | 1977-03-02 |
FR2322597B1 (sv) | 1980-04-25 |
IE43313B1 (en) | 1981-01-28 |
ES451175A1 (es) | 1977-09-01 |
IE43313L (en) | 1977-03-03 |
DE2634910B2 (de) | 1979-11-22 |
ATA653976A (de) | 1979-11-15 |
DK396676A (da) | 1977-03-04 |
AT357158B (de) | 1980-06-25 |
FR2322597A1 (fr) | 1977-04-01 |
CA1063115A (en) | 1979-09-25 |
MX4817E (es) | 1982-10-20 |
NL7609772A (nl) | 1977-03-07 |
JPS5233693A (en) | 1977-03-14 |
DE2634910C3 (de) | 1980-08-14 |
US4163745A (en) | 1979-08-07 |
DE2634910A1 (de) | 1977-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
SE429961B (sv) | Forfarande for framstellning av mjolksyra | |
SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
SE7613565L (sv) | Forfarande for framstellning av fusidinsyraderivat | |
AR217629A1 (es) | Procedimiento de preparacion de derivados de tienotetrahidropiridina | |
NO821848L (no) | Fremgangsmaate for fremstilling av gamma-pyron-derivater | |
SE434263B (sv) | Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan | |
NO146058C (no) | Analogifremgangsmaate for fremstilling av substituerte benzamider | |
SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
SE427841B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
SE7609719L (sv) | Forfarande for framstellning av kvaternera salter | |
SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
SE421793B (sv) | Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat | |
SE423814B (sv) | Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat | |
SE7604669L (sv) | Forfarande for framstellning av estrar av tiokarbamidsyror | |
SE7607322L (sv) | Forfarande for framstellning av 16-etrar av fusidinsyraderivat | |
SE446726B (sv) | Forfarande for framstellning av 16-metoxiprostaglandiner | |
SE7610637L (sv) | Forfarande for framstellning av 2-alkylindaner | |
SE7607026L (sv) | Forfarande for framstellning av 5-alkylpikolinsyra | |
SE7604940L (sv) | Forfarande for framstellning av sulfamylbensoesyror | |
SE427840B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat |